JPMorgan Downgrades Abbvie (ABBV) to Neutral
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $167.89 +0.89%
Rating Summary:
20 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 3 | New: 2
Rating Summary:
20 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 3 | New: 2
Join SI Premium – FREE
JPMorgan downgraded Abbvie (NYSE: ABBV) from Overweight to Neutral with a price target of $73.00 (from $75.00).
For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.
Shares of Abbvie closed at $64.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Roblox Corp. (RBLX) to Overweight
- Cisco Systems (CSCO) given neutral at JPMorgan despite favorable near-term setup
- CLSA Downgrades Reliance Industries (RIL:IN) to Outperform (2)
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
